Image Credit:J Cell Mol Anesth
Outline
The role of Toll-like receptors in pain control
Authors
Abstract
The Toll like (family of receptors TLR) are expressed primarily by immune cells and are known to be part of innate immune system. In the past decade involvement of TLRs in several physiologic and pathologic pathways has been proved. Pain transmission via glial activation is one of such interesting fields. Both pathological pain states and treatment have also been shown to be related to TLR-related pathways. Opioid agonists are found to possess TLR4 agonistic effects and glial activity. Targeting TLRs could be a novel method for treatment of neuropathic pain. Moreover attenuation of glial activation by the aim of selective TLR antagonistic drugs, may become a preferred way of separating the beneficial (analgesia) and unwanted effects of opioids, improving their safety and efficacy.
Highlights
References
- 1.References are in the PDF file of the article.
Copyright
© 2017, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Toll-Like Receptor 4 in Ventilator-Induced Lung Injuries
Bagheri B, Razavi S, Gohari A, Salarian S, Dabbagh A. Toll-Like Receptor 4 in Ventilator-Induced Lung Injuries. J Cell Mol Anesth. 2016;1(1):e150239. doi: https://doi.org/10.22037/jcma.v1i1.10579
Contemplating the Importance of Toll-like Receptors I and II Regarding Human Viral Pathogenesis
Saeed U, Mazoor S, Jalal N, Zahid Piracha Z. Contemplating the Importance of Toll-like Receptors I and II Regarding Human Viral Pathogenesis. Jundishapur J Microbiol. 2015;8(1):e13348. doi: https://doi.org/10.5812/jjm.13348
The Role of Toll-Like Receptors in Breast Cancer
Nokhandani N, Naghavi Alhosseini M, Davoodi H. The Role of Toll-Like Receptors in Breast Cancer. J Inflamm Dis. 2024;23(3):e156167. doi:
FDA Approved Drugs Repurposing of Toll-Like Receptor4 (TLR4) Candidate for Neuropathy
Zali H, Golchin A, Farahani M, Yazdani M, Ranjbar MM, et al. FDA Approved Drugs Repurposing of Toll-Like Receptor4 (TLR4) Candidate for Neuropathy. Iran J Pharm Res. 2019;18(3):e126188. doi: https://doi.org/10.22037/ijpr.2019.2394
Toll-Like Receptor 4 in Acute Respiratory Distress Syndrome: Good Time to Target?
Bagheri B, Salarian S. Toll-Like Receptor 4 in Acute Respiratory Distress Syndrome: Good Time to Target?. J Cell Mol Anesth. 2020;5(4):e149659. doi: https://doi.org/10.22037/jcma.v5i4.32430
- Scopus by DOI: 5
Last Update: 4 days ago
- Scopus by Title: 5
Last Update: 4 days ago
- Scopus by Title (Ref): 5
Last Update: 4 days ago
- CrossRef: 0
Last Update: 6 days ago
- OpenAlex: 3
Last Update: 8 hours ago
- OpenCitations: 0
Last Update: 4 days ago